Stock Movers Intel Falls, Dynavax Climbs, Snowflake Slides
Dec 24, 2025
Natalia Kaninjavich, a Bloomberg equities reporter, dives into the stock market dynamics of the day. She discusses Intel's plummeting shares after Nvidia paused a key chip production test. Dynavax experiences a surge following Sanofi's $2.2 billion acquisition offer to enhance its vaccine portfolio. Meanwhile, Snowflake's stock slides amid reports of a potential $1 billion deal to acquire Observe Inc., seen as a strategic move to compete with Databricks. Tune in for insights on these market shifts!
AI Snips
Chapters
Transcript
Episode notes
Intel's Turnaround Faces A Test
- Nvidia paused tests using Intel's 18A process, denting investor confidence in Intel's turnaround.
- The Nvidia-Intel $5B cooperation still exists but uncertainty now clouds Intel's manufacturing narrative.
Sanofi Expands Vaccines With Dynavax Deal
- Sanofi agreed to acquire Dynavax for about $2.2 billion, boosting Dynavax shares sharply.
- The deal gives Sanofi access to vaccine assets as it seeks revenue growth amid challenges in its vaccine business.
Snowflake Eyes Observe To Boost Competitiveness
- Snowflake is reportedly in talks to buy Observe for around $1 billion to bolster observability capabilities.
- Analysts say the move could help Snowflake better compete with acquisitive rivals like Databricks.